Vigabatrin Therapy
Vigabatrin Therapy is a pharmacotherapeutic intervention that involves the administration of vigabatrin, an irreversible GABA transaminase inhibitor, to selectively enhance central nervous system GABAergic neurotransmission for the management of refractory pediatric epilepsy syndromes, notably infantile spasms and tuberous sclerosis complex-associated seizures.
531
Publications
26.7K
Citations
2.1K
Authors
640
Institutions
Publications per year
2017–2026
44
531
Andrew Lux, Stuart W. Edwards, Eleanor Hancock et al. · The Lancet Neurology · 2005 · 401 citations
Evidence-based guideline update: Medical treatment of infantile spasms [RETIRED]
Cristina Go, Mark T. Mackay, Shelly K. Weiss et al. · Neurology · 2012 · 337 citations · Full text
Medicine, Neurology, Pharmacotherapy +13
1–5 of 531
2.1K
17
h-index
15
h-index
12
h-index
12
h-index
11
h-index
1–5 of 2.1K
640
University College London
London, United Kingdom
25 h-index
94 publications
6K citations
National Hospital for Neurology and Neurosurgery
London, United Kingdom
20 h-index
59 publications
3.2K citations
Inserm
Paris, France
17 h-index
80 publications
5.7K citations
Hôpital Saint-Vincent-de-Paul
Paris, France
16 h-index
50 publications
4.7K citations

University of Eastern Finland
Joensuu, Finland
14 h-index
62 publications
3.1K citations
Western Infirmary
Glasgow, United Kingdom
12 h-index
34 publications
1.6K citations

Boston Children's Hospital
Boston, United States
12 h-index
44 publications
1.7K citations
Hospital for Sick Children
Toronto, Canada
12 h-index
57 publications
2.2K citations
1–8 of 640
85 publications · 4.9K citations
43
h-index
29 publications · 2.6K citations
25
h-index
33 publications · 1.7K citations
22
h-index
JCN · 26 publications · 1.2K citations
21
h-index
BJCP · 22 publications · 1.2K citations
19
h-index
1–5